Robert Greenfield
About Robert Greenfield
Robert Greenfield is the Chief Science Officer and Co-Founder of Vita-You Solutions/CTerm Diagnostics, specializing in biochemistry and cancer diagnostics.
Title and Role
Robert Greenfield serves as the Chief Science Officer at Vita-You Solutions and Vitacyclix, as well as a co-founder and Chief Science Officer of CTerm Diagnostics. His work spans across different geographic locations including Yonkers, New York, and Winchester, UK. He focuses on overseeing scientific research and development initiatives at these organizations.
Education and Expertise
Robert Greenfield earned his Doctor of Philosophy (PhD) in Biochemistry from Joan & Sanford I. Weill Medical College of Cornell University, completing his studies from 1971 to 1976. His expertise is predominantly in the field of biochemistry, with a specialization in manufacturing water-soluble vitamins A, D, E, and K, as well as other fat-soluble bioflavonoids and nutrients. His academic and professional background center on the development of proprietary emulsion technology and innovative health solutions.
Innovative Product Development
Greenfield co-developed Fungicycle, an all-natural treatment for fungal foot infections that has been gaining approval from podiatrists for its effectiveness in treating toenail fungus. In addition, he developed Acnecycle, a product recognized by dermatologists for its efficacy in treating acne, eczema, and psoriasis. These developments highlight his role in creating impactful dermatological treatments.
Scientific Contributions in Cancer Diagnostics
At C-Term Diagnostics, Robert Greenfield works on developing clinical laboratory kits and point-of-care rapid immunodiagnostic tests for cancer detection and monitoring. His research includes focusing on the tissue factor phosphorylation system (TFPS) expressed in the kidney for cancer diagnostics. Furthermore, he has significantly contributed to the development of biomarkers used in the detection and staging of bladder and colon cancer through clinical studies.